Litcius/Paper detail

Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes after Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia

Leonardo Javier Arcuri, Samir Nabhan, Renato Cunha, Samantha Nichele, Andreza Alice Feitosa Ribeiro, Juliana Folloni Fernandes, Liane Esteves Daudt, Ana Luiza Melo Rodrigues, Celso Arrais‐Rodrigues, Adriana Seber, Elias Hallack Atta, José Salvador Rodrigues de Oliveira, Vaneuza Araújo Moreira Funke, Gisele Loth, Luiz Guilherme Darrigo, Alessandra Aparecida Paz, Rodolfo Calixto, Alessandra Araújo Gomes, Carlos E. Araujo, Vergílio Antônio Rensi Colturato, Belinda Pinto Simões, Nelson Hamerschlak, Mary E.D. Flowers, Ricardo Pasqüini, Vanderson Rocha, Carmem Bonfim

2020Biology of Blood and Marrow Transplantation48 citationsDOI

Topics & Concepts

MedicineTotal body irradiationFludarabineCyclophosphamideTransplantationSurgeryInternal medicineHematopoietic stem cell transplantationAplastic anemiaGastroenterologyBone marrowChemotherapyHematopoietic Stem Cell TransplantationMesenchymal stem cell researchT-cell and B-cell Immunology
Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes after Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia | Litcius